D
$ Value
$4K
Shares
1,601
Price
$3
Filed
May 22
Insider
Name
Carter Robert Ross
Title
Chief Financial Officer
CIK
0002039341
Roles
Officer
Transaction Details
Transaction Date
2025-05-21
Code
D
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
235,174
Footnotes
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
Filing Info
Carter Robert Ross's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-27 | TOI | A | $0 |
| 2026-03-27 | TOI | J | $62K |
| 2025-05-21 | TOI | D | $4K |
Other Insiders at TOI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Chernett Jorey | $689K | — | 2026-04-09 |
| Kaushal Mohit | — | $335K | 2026-04-16 |
|
Podnos Yale
Chief Medical Officer
|
— | — | 2026-03-27 |
|
Virnich Daniel
Chief Executive Officer
|
— | — | 2026-03-27 |
|
Carter Robert Ross
Chief Financial Officer
|
— | — | 2026-03-27 |
|
Langsam Jeffrey
Chief Clinical Officer
|
— | — | 2026-03-27 |
|
England Kristin
Chief Administrative Officer
|
— | — | 2026-03-27 |